Artículos del autor

solaci

Institutional News

SOLACI Peripheral Registry Surpassed the 500-Patient Mark

We are glad to announce that the Latin American SOLACI Peripheral Registry keeps growing and has enrolled...
solaci -
Structural Heart Disease

ACC 2022 | APOLLO

Lipoprotein a (Lp a) is an important risk factor for atherothrombosis and atherosclerotic cardiovascular disease, but it...
solaci -
Chronic Ischemic cardiopathy

CRUNCH Registry: An Option for Underexpanded Stents

Coronary calcification hinders both stent transfer and implantation, and has been associated with a higher risk of...
solaci -
Femoropopliteal

Should We Start Stenting with DES in Femoropopliteal Territory?

Percutaneous intervention of femoropopliteal lesions have been the standard strategy these past two decades. The development of...
solaci -
Institutional News

Survey to Evaluate Myocardial Infarction Reperfusion in LatAm

The Latin American Society of Interventional Cardiology together with the Interamerican Society of Cardiology (SIAC) and the...
solaci -
Coronary Disease

ACC 2022 – EDIT-CMD

Roughly 40% of patients receiving a coronary angiography for stable angina (angina episodes twice a week despite...
solaci -
Acute coronary syndromes

ACC 2022 – Complete Trial QoL: Complete Revascularization in STEMI

The COMPLETE study has shown complete revascularization in STEMI reduces cardiovascular mortality or new AMI, which generated...
solaci -
Pharmacology

ACC 2022 | VALOR-HCM: Mavacamten in Adults with Symptomatic Obstructive HCM Eligible for Septal Reduction Therapy

Roughly 50% of hypertrophic cardiomyopathies (HCM) are obstructive, and of this percentage, most of symptoms can be...
solaci -